Literature DB >> 9374673

Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats.

K X Liu1, Y Kato, M Kato, T I Kaku, T Nakamura, Y Sugiyama.   

Abstract

Nonlinearity in the overall elimination of hepatocyte growth factor (HGF) was examined in rats. After intravenous administration, the plasma clearance (CLplasma) of HGF exhibited a dose-dependent biphasic reduction with high- and low-affinity components. If we consider our previous finding that both receptor-mediated endocytosis (RME) and a low-affinity uptake mechanism, probably mediated by heparan sulfate proteoglycan (HSPG), in the liver are major HGF clearance mechanisms, it may be that saturation of CLplasma at lower and higher doses represents saturation of RME and HSPG-mediated uptake, respectively. At an HGF dose (1.46 nmol/kg), which completely saturates the high-affinity component, CLplasma was almost completely reduced when HGF was premixed with heparin. However, CLplasma was reduced by heparin to, at most, one-fifth that after HGF alone in a dose near the linear range (3.66 pmol/kg). Saturation of CLplasma for HGF premixed with heparin was monophasic and nonlinear only at the lowest HGF doses. In vitro, high-affinity binding of [35S]heparin to HGF was found, showing that one HGF molecule binds to the penta- or hexasaccharide unit. Because mitogenic activity of HGF has been reported in the presence of heparin, these results suggest that heparin mainly inhibits low-affinity HGF uptake by complexing with HGF, whereas its effect on RME is relatively minor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374673     DOI: 10.1152/ajpendo.1997.273.5.E891

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Kinetic analysis of the disposition of insulin-like growth factor 1 in healthy volunteers.

Authors:  N Mizuno; Y Kato; M Iwamoto; A Urae; T Amamoto; T Niwa; Y Sugiyama
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

3.  Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.

Authors:  Ke-Xin Liu; Yukio Kato; Kunio Matsumoto; Toshikazu Nakamura; Taiichi Kaku; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2009-01-06       Impact factor: 4.200

4.  Hepatocyte growth factor in patients with coronary artery disease and its relation to periodontal condition.

Authors:  J Lönn; C Starkhammar Johansson; H Kälvegren; L Brudin; C Skoglund; P Garvin; E Särndahl; N Ravald; A Richter; T Bengtsson; F Nayeri
Journal:  Results Immunol       Date:  2011-12-30

5.  Liver Failure Impairs the Intrahepatic Elimination of Interleukin-6, Tumor Necrosis Factor-Alpha, Hepatocyte Growth Factor, and Transforming Growth Factor-Beta.

Authors:  Dawid Porowski; Agnieszka Wirkowska; Ewa Hryniewiecka; Janusz Wyzgał; Marek Pacholczyk; Leszek Pączek
Journal:  Biomed Res Int       Date:  2015-05-21       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.